Fed. Circ. Revives Astellas Patent Axed As Natural Law
By Ryan Davis · September 18, 2024, 9:29 PM EDT
The Federal Circuit on Wednesday vacated a lower court's invalidation of an Astellas Pharma overactive bladder medication patent for claiming only a natural law, saying the holding was improper because the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login